Lipoprotein(a) and kidney diseases-Reference-Cited by-同舟云学术

Lipoprotein(a) and kidney diseases

Published:2021-01-21 Issue:1 Volume:25 Page:31-46
ISSN:2541-9439
Container-title:Nephrology (Saint-Petersburg)
language:
Short-container-title:Nefrologiâ (St.-Peterbg.)

Author:

Pyatchenkov M. O.¹^ORCID,Rumyantsev A. Sh.²^ORCID,Zakharov M. V¹^ORCID,Sherbakov E. V.¹^ORCID,Belskykh A. N.¹^ORCID

Affiliation:

1. Military Medical Academy S.M. Kirov

2. St. Petersburg University; Pavlov First Saint Petersburg State Medical University

Publisher

Non-profit organization Nephrology

Subject

General Medicine

Reference104 articles.

1. Benjamin E, Blaha M, Chiuve S et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation 2017;135(10):e146-e603. doi: 10.1161/CIR.0000000000000485

2. Tsimikas S. A Test in Context: Lipoprotein(a): Diagnosis, Prognosis, Controversies, and Emerging Therapies. J Am Coll Cardiol 2017;69(6):692-711. doi: 10.1016/j.jacc.2016.11.042

3. Kukharchuk V, Yezhov M, Sergienko I et al. Diagnostics and correction of lipid metabolism disorders for the prevention and treatment of atherosclerosis Russian recommendations, VII revision. Atherosclerosis and Dyslipidemias 2020; 1 (38): 7-40. doi: 10.34687/2219-8202.JAD.2020.01.0002

4. Mach F, Baigent C, Catapano A et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J 2020;41(1):111-188. doi: 10.1093/eurheartj/ehz455

5. Zychlinski A, Kleffmann T, Williams M et al. Proteomics of lipoprotein (a) identifies a protein complement associated with response to wounding. Journal of Proteomics 2011;74(12):2881-2891. doi: 10.1016/j.jprot.2011.07.008